Atlas Trials

Safety Study of the Switch From Oral Selexipag to Intravenous Selexipag in Subjects With Stable Pulmonary Arterial Hypertension

Clinical trial NCT03187678 · COMPLETED

Trial details

NCT number
NCT03187678
Sponsor
Actelion
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pulmonary Arterial Hypertension
Start date
2017-12-04
Primary completion
2018-05-29
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.